Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials

This publication has 35 references indexed in Scilit:

• Analysis of Body Mass Index and Mortality in Patients With Colorectal Cancer Using Causal Diagrams
  JAMA Oncology, 2016
• Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD Database
  Journal of Clinical Oncology, 2016
• Adiposity and cancer risk: new mechanistic insights from epidemiology
  Nature Reviews Cancer, 2015
• Association between Body Mass Index and Prognosis of Colorectal Cancer: A Meta-Analysis of Prospective Cohort Studies
  PLOS ONE, 2015
• Global burden of cancer attributable to high body-mass index in 2012: a population-based study
  The Lancet Oncology, 2015
• Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013
  The Lancet, 2014
• Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy
  Cancer, 2013
• Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline
  Journal of Clinical Oncology, 2012
• Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy
  European Journal of Cancer, 2011
• Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer
  Gut, 2009